119 related articles for article (PubMed ID: 31100523)
1. Podoplanin Expression and IDH-Wildtype Status Predict Venous Thromboembolism in Patients with High-Grade Gliomas in the Early Postoperative Period.
Watanabe J; Natsumeda M; Okada M; Kanemaru Y; Tsukamoto Y; Oishi M; Kakita A; Fujii Y
World Neurosurg; 2019 Aug; 128():e982-e988. PubMed ID: 31100523
[TBL] [Abstract][Full Text] [Related]
2. Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.
Ando K; Natsumeda M; Kawamura M; Shirakawa K; Okada M; Tsukamoto Y; Eda T; Watanabe J; Saito S; Takahashi H; Kakita A; Oishi M; Fujii Y
Thromb Res; 2023 Mar; 223():36-43. PubMed ID: 36706720
[TBL] [Abstract][Full Text] [Related]
3. Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism.
Mir Seyed Nazari P; Riedl J; Preusser M; Posch F; Thaler J; Marosi C; Birner P; Ricken G; Hainfellner JA; Pabinger I; Ay C
J Thromb Haemost; 2018 Jun; 16(6):1121-1127. PubMed ID: 29676036
[TBL] [Abstract][Full Text] [Related]
4. Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.
Low SK; Anjum Z; Mahmoud A; Joshi U; Kouides P
Thromb Res; 2022 Nov; 219():14-21. PubMed ID: 36088710
[TBL] [Abstract][Full Text] [Related]
5. Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.
Diaz M; Jo J; Smolkin M; Ratcliffe SJ; Schiff D
Neurology; 2021 Feb; 96(7):e1063-e1069. PubMed ID: 33361259
[TBL] [Abstract][Full Text] [Related]
6. Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma.
Osada Y; Saito R; Miyata S; Shoji T; Shibahara I; Kanamori M; Sonoda Y; Kumabe T; Watanabe M; Tominaga T
Brain Tumor Pathol; 2021 Jul; 38(3):218-227. PubMed ID: 34269949
[TBL] [Abstract][Full Text] [Related]
7. Determining venous thromboembolism risk in patients with adult-type diffuse glioma.
Burdett KB; Unruh D; Drumm M; Steffens A; Lamano J; Judkins J; Schwartz M; Javier R; Amidei C; Lipp ES; Peters KB; Lai A; Eldred BSC; Heimberger AB; McCortney K; Scholtens DM; Horbinski C
Blood; 2023 Mar; 141(11):1322-1336. PubMed ID: 36399711
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.
Riedl J; Preusser M; Nazari PM; Posch F; Panzer S; Marosi C; Birner P; Thaler J; Brostjan C; Lötsch D; Berger W; Hainfellner JA; Pabinger I; Ay C
Blood; 2017 Mar; 129(13):1831-1839. PubMed ID: 28073783
[TBL] [Abstract][Full Text] [Related]
9. IDH mutation status and the development of venous thromboembolism in astrocytoma patients.
Mandel JJ; Youssef M; Yust-Katz S; Patel AJ; Jalali A; Li Z; Wu J; Ludmir EB; de Groot JF
J Neurol Sci; 2021 Aug; 427():117538. PubMed ID: 34146775
[TBL] [Abstract][Full Text] [Related]
10. Venous Thromboembolism in Brain Tumors: Risk Factors, Molecular Mechanisms, and Clinical Challenges.
Riedl J; Ay C
Semin Thromb Hemost; 2019 Jun; 45(4):334-341. PubMed ID: 31041803
[TBL] [Abstract][Full Text] [Related]
11. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas with MRI: Single-Shell versus Multishell Diffusion Models.
Figini M; Riva M; Graham M; Castelli GM; Fernandes B; Grimaldi M; Baselli G; Pessina F; Bello L; Zhang H; Bizzi A
Radiology; 2018 Dec; 289(3):788-796. PubMed ID: 30277427
[TBL] [Abstract][Full Text] [Related]
13. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
14. Screening strategy using sequential serum D-dimer assay for the detection and prevention of venous thromboembolism after elective brain tumor surgery.
Aishima K; Yoshimoto Y
Br J Neurosurg; 2013 Jun; 27(3):348-54. PubMed ID: 23131147
[TBL] [Abstract][Full Text] [Related]
15. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Karsy M; Guan J; Huang LE
J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.
Thaler J; Ay C; Kaider A; Reitter EM; Haselböck J; Mannhalter C; Zielinski C; Marosi C; Pabinger I
Neuro Oncol; 2014 Dec; 16(12):1645-51. PubMed ID: 24987133
[TBL] [Abstract][Full Text] [Related]
18. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.
Yang Y; Mao Q; Wang X; Liu Y; Mao Y; Zhou Q; Luo J
J Clin Neurosci; 2016 Sep; 31():56-62. PubMed ID: 27406953
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
20. A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.
Streiff MB; Ye X; Kickler TS; Desideri S; Jani J; Fisher J; Grossman SA
J Neurooncol; 2015 Sep; 124(2):299-305. PubMed ID: 26100546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]